MAPT and myeloid sarcoma: Studies by Brettschneider et al. [28] measured CSF levels of the axonal cytoskeletal proteins microtubule-associated protein tau and pNF-H in the same MS patients to ascertain whether this could improve the sensitivity of predicting disability progression relative to conventional MRI methods.